Pulmonary giant cell carcinoma: pathological entity or morphological phenotype?

doi:10.1046/j.1365-2559.1998.00378.x

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Pulmonary giant cell carcinoma: pathological entity or morphological phenotype?

Histopathology - 1 Mar 1998

Attanoos R L, Papagiannis A, Suttinont P, Goddard H, Papotti M, Gibbs A R

Abstract excerpt

AIMS: To evaluate the morphological spectrum and clinical significance of giant cell carcinoma and to assess the frequency of tumour giant cell production in a consecutive series of primary (non-giant cell) lung tumours. METHODS AND RESULTS: Forty-six cases of giant cell carcinoma of the lung wer...

Topics

Adenocarcinoma
Adenocarcinoma, Clear Cell
Adult
Aged
Carcinoembryonic Antigen
Carcinoma
Carcinoma, Giant Cell
Carcinoma, Non-Small-Cell Lung
Chorionic Gonadotropin
Female
Humans
Immunohistochemistry
Lung Neoplasms
Male
Middle Aged
Phenotype
Prognosis
alpha 1-Antitrypsin

Source

Open in PubMed

Identifiers

PMID: 9568507
DOI: 10.1046/j.1365-2559.1998.00378.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026. Prepared record publication-9568507-2026-08-30.1. Manifest publication-graph-cohort-2026-08-30.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics